Wanda Launches CareLink, New Digital Health App

RNS Number : 7719X
NetScientific PLC
15 August 2018
 

 

 

NetScientific plc

("NetScientific" or the "Group")

 

Wanda launches new digital health app Wanda CareLink™ with enhanced real-time capabilities on iOS and Android devices

 

London, UK - August 15, 2018 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that portfolio company Wanda, which uses machine learning to help healthcare providers to better manage the risk and care of patients, has launched its new digital health application Wanda CareLink™. This application allows the Wanda Patient Management solution to be used on a wide variety of internet-enabled devices including iOS and Android devices. This enhances the ability for patients and doctors alike to improve clinical and financial outcomes.

 

The application is available on the Apple Store and is to become available on Google Play shortly.

 

Commenting on the news, Francois R. Martelet, NetScientific's Chief Executive Officer and Chairman of Wanda, said: "Wanda continues to improve its capabilities to match the needs of the market and its clients, and we believe that it will result in increased traction as healthcare providers realise the value of remote patient monitoring from both a financial and clinical standpoint. We are pleased to see Wanda's progress in strengthening its core offering and look forward to further progress."

 

NetScientific holds a 62% stake on a fully diluted basis in Wanda. The full announcement is included below.

 

For more information, please contact:

 

  NetScientific

  François R. Martelet, M.D., CEO

  Ian Postlethwaite, CFO

Tel: +44 (0)20 3514 1800

  Wanda, Inc.

  Bill Basset, CCO

   

     Tel: +1 (0)206 910 0428

  Consilium Strategic Communications

  Mary-Jane Elliott / Chris Welsh / Laura Thornton  

 

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

WHIreland (NOMAD and Broker)

Chris Fielding / Jessica Cave / Chris Viggor

Tel: +44 (0)20 7220 1666

 

 

About NetScientific

 

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net

 

 

Predictive Patient Management Platform Expands Real-Time Mobile Capabilities

August 15, 2018 (San Francisco, CA) -- Wanda is pleased to announce the release of its new digital health application Wanda CareLink. The multi-platform application greatly expands the mobility of the Wanda Patient Management solution to be used on virtually any internet-enabled device including iOS and Android smartphones and tablets. The "bring-your-own-device" approach expands the ability for patients, doctors, and clinicians to improve care plan adherence producing better clinical and financial outcomes. 

The Wanda platform empowers doctors and clinicians with the ability to know when patients will have adverse events before they happen, predicting 90% of rehospitalizations and emergency department visits seven days before they occur. The embedded predictive algorithms identify high-risk patients, alerting doctors and clinicians to the root-causes triggering the adverse events. These insights help clinical teams to assess care plans and proactively manage virtual interventions, which improve patient care plan adherence and resolve the adverse event before it happens.

"Wanda is proving to be a great solution for supporting preventative patient engagement with 74% of patients staying adherent to their care plan," stated William Bassett, Chief Commercial Officer at Wanda. "As high-risk patients are identified, Wanda facilitates better decision making, empowering doctors and clinicians with the real-time insight that will keep patients from preventable emergent situations."

The Wanda application was created from twelve years of research at UCLA, in a collaborative research project including the Medical, Nursing and Engineering Schools. After eight clinical trials yielding nine patents, the machine learning clinical algorithms have shown to predict 90% of adverse events, rehospitalizations and ED visits, seven days before the event will occur. Wanda warns of the pending adverse event detailing the risk triggers for each patient prompting the need for intervention and then facilitates clinical case management.

"Providers and payers can more easily identify and eliminate issues that have made population health and risk-based contracting a challenge," said Ahsan Samiee, Chief Technology Officer at Wanda. "The embedded data science in Wanda can now be used across a range of mobile tools to expand the efficiency of real-time patient care."

 

About Wanda, Inc.

Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning and modern software applications that empower payers and providers to better manage the risk and care of patients dramatically lowering the cost of care and improving outcomes. More information about Wanda can be found at http://www.yourwanda.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFEITFISLIT
UK 100

Latest directors dealings